GeoVax Labs, Inc. (GOVX)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue from government contract | 852,282 | 1,636,863 | 2,789,484 | 300,677 |
| Research and development | 4,728,998 | 5,354,588 | 7,402,884 | 4,276,868 |
| General and administrative | 1,542,190 | 1,687,445 | 1,241,176 | 1,086,030 |
| Total operating expenses | 6,271,188 | 7,042,033 | 8,644,060 | 5,362,898 |
| Loss from operations | -5,418,906 | -5,405,170 | -5,854,576 | -5,062,221 |
| Interest income | 49,123 | 47,519 | 53,191 | 5,471 |
| Interest expense | - | - | 14,083 | 7,292 |
| Total other income (expense) | 49,123 | - | 39,108 | -1,821 |
| Net loss | -5,369,783 | -5,357,651 | -5,815,468 | -5,064,042 |
| Net loss per common share (in dollars per share) | -0.35 | -0.45 | -0.91 | -1.99 |
| Weighted average shares outstanding (in shares) | 15,359,220 | 11,954,797 | 6,404,797 | 2,539,878 |